Jason Haas
2021
In 2021, Jason Haas earned a total compensation of $2.5M as Chief Financial Officer at Syros Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $42,460 |
|---|---|
| Option Awards | $2,361,150 |
| Salary | $91,385 |
| Other | $144 |
| Total | $2,495,139 |
Haas received $2.4M in option awards, accounting for 95% of the total pay in 2021.
Haas also received $42.5K in non-equity incentive plan, $91.4K in salary and $144 in other compensation.
Rankings
In 2021, Jason Haas' compensation ranked 5,157th out of 12,415 executives tracked by ExecPay. In other words, Haas earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,157 out of 12,415 | 59th |
Division Manufacturing | 2,168 out of 5,508 | 61st |
Major group Chemicals And Allied Products | 935 out of 2,378 | 61st |
Industry group Drugs | 836 out of 2,099 | 60th |
Industry Pharmaceutical Preparations | 599 out of 1,549 | 61st |
Source: SEC filing on April 21, 2022.
Haas' colleagues
We found three more compensation records of executives who worked with Jason Haas at Syros Pharmaceuticals in 2021.